Catalyst Wire Dossier Catalyst Wire Dossier

OM-89

Escherichia coli lysate OM-89
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OM-89, covering 2024-04-04 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Assess the Efficacy of OM-89 vs Placebo in Reducing Antibiotic Consumption Associated With the Treatment of Urinary Tract Infections in Patients With Neurogenic Bladder [Phase 3]

See pricing